Skip to main content
OpenTrials

Clinical trial condition

DLBCL - Diffuse Large B Cell Lymphoma

Explore clinical trials studying DLBCL - Diffuse Large B Cell Lymphoma. Study availability and eligibility vary by location and protocol.

41 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

DLBCL - Diffuse Large B Cell Lymphoma trial results

Recruiting

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

NCT07121946

Conditions
DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma ( FL), +18 more
Locations
  • City of Hope Duarte, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Memorial Sloan Kettering Cancer Center - Bergen New York, United States
View Trial Details
Recruiting

CAR-T Followed by Bispecific Antibodies

NCT04889716

Conditions
DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
Locations
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

NCT06544265

Conditions
Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View Trial Details
Recruiting

DALY II Japan/MB-CART2019.1 for DLBCL

NCT07288879

Conditions
CAR T Cell Therapy, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +6 more
Locations
  • National Cancer Center Hospital Tokyo, Japan
  • Toranomon Hospital Tokyo, Japan
  • Juntendo University Hospital Tokyo, Japan
  • Tokyo Metropolitan Komagome Hospital Tokyo, Japan
View Trial Details
Recruiting

Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma

NCT06220032

Conditions
Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +22 more
Locations
  • NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands
  • NL-Almelo-ZGTALMELO Almelo, Netherlands
  • NL-Amstelveen-AMSTELLAND Amstelveen, Netherlands
  • NL-Apeldoorn-GELREAPELDOORN Apeldoorn, Netherlands
View all 25 locations
View Trial Details

Related conditions